CD274 and neoplasm: Analysis of BOR and change in lesion size by PD-L1 expression and tumor immunophenotype showed that 2 of 3 responders (66.7%) had immune-excluded tumors and 1 responder (33.33%) had an immune-desert tumor (Figure 2).